SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Daleen Technologies, Inc.
-------------------------
(Name of Issuer)
Common Stock, $.01 par value
----------------------------
(Title of Class of Securities)
23437N10
--------
(CUSIP Number)
Douglas E. Scott, Esq.
Senior Vice President and General Counsel
Science Applications International Corporation
10260 Campus Point Drive
San Diego, CA 92121
(858) 826-7325
--------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
With a copy to:
Aloma H. Avery, Esq.
Senior Counsel
Science Applications International Corporation
10260 Campus Point Drive
San Diego, CA 92121
Tel: (858) 826-6000
August 9, 2001
------------------------------------------------
(Date of Event which Requires Filing of Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. [X]
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(CONTINUED ON FOLLOWING PAGE(S))
Page 1 of 5
--------------------------------------------------------------------------------
CUSIP No. 23437N10
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS:
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS:
Science Applications International Corporation 95-3630868
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [__]
(b) [__]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS) N/A
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [__]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER None
NUMBER OF SHARES --------------------------------------------------
BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 13,836,046
EACH REPORTING PERSON --------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER None
--------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER 13,836,046
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY
EACH REPORTING PERSON 13,836,046
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [__]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (11) 41.3%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO
--------------------------------------------------------------------------------
Page 2 of 5
--------------------------------------------------------------------------------
CUSIP No. 23437N10
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS:
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS:
SAIC Venture Capital Corporation 88-0447177
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [__]
(b) [__]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [__]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION Nevada
--------------------------------------------------------------------------------
7 SOLE VOTING POWER None
NUMBER OF SHARES --------------------------------------------------
BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 13,836,046
EACH REPORTING PERSON --------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER None
--------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER 13,836,046
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY
EACH REPORTING PERSON 13,836,046
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [__]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (11) 41.3%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO
--------------------------------------------------------------------------------
Page 3 of 5
AMENDMENT NO. 1 TO SCHEDULE 13D
The Reporting Persons, Science Applications International Corporation
("SAIC") and SAIC Venture Capital Corporation ("SVCC"), hereby amend and
supplement the Schedule 13D filed by SAIC on June 18, 2001 (the "Original
Statement") with regard to the Series F Preferred Stock ("Series F Preferred")
and Warrants ("Series F Warrants") of Daleen Technologies, Inc. (the "Issuer")
for the purpose of amending Items 2, 4, 5 and 6 of the Original Statement.
ITEM 2. IDENTITY AND BACKGROUND.
Item 2 (a)-(c) of the Original Statement are hereby supplementally
amended to add Mr. Neil E. Cox as an Executive Officer of SAIC, and to amend
Appendix A to the Original Statement as follows:
NAME TITLE (AND ADDRESS, IF OTHER THAN AS INDICATED ABOVE)
Neil E. Cox Executive Vice President
ITEM 4. PURPOSE OF TRANSACTION.
The response set forth in Item 4 (d) of the Original Statement is
hereby supplementally amended and restated in its entirety to read as follows:
(d) Effective June 12, 2001, Neil E. Cox resigned from the Issuer's
Board of Directors. On June 4, 2001, Mr. Cox joined SAIC as an employee and on
July 13, 2001, he became an Executive Vice President of SAIC.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
The response set forth in Items 5 (a) and (b) of the Original Statement
are hereby supplementally amended and restated in their entirety to read as
follows:
(a) SVCC directly owns 2,246,615 shares of Common Stock, 67,604
shares of Series F Preferred with each share immediately convertible into
122.4503 shares of Common Stock and Series F Warrants to purchase 27,042
shares of Series F Preferred with each share immediately convertible into
122.4503 shares of Common Stock. Together these interests represent a total
of 13,836,046 shares or approximately 41.3% of the Common Stock of the
Issuer. According to the Issuer's Quarterly Report on Form 10-Q for the
period ending June 30, 2001 ("10-Q"), filed with the Commission on August 14,
2001, the number of shares of Common Stock outstanding as of August 6, 2001
was 21,872,951 (before giving effect to the 8,278,130 shares of Common Stock
issuable upon the conversion of the shares of Series F Preferred held by SVCC
and the 3,311,301 shares of Common Stock issuable upon the conversion of the
shares of Series F Preferred issuable upon the exercise of the Series F
Warrants held by SVCC). For reporting purposes, SAIC may be deemed the
beneficial owner of the shares owned by SVCC.
(b) For reporting purposes, SVCC and SAIC may be deemed to share voting
and dispositive powers with respect to the 13,836,046 shares of Common Stock.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
The response set forth in Item 6 of the Original Statement is hereby
supplementally amended to add the following information:
The final Reset Price was established based on the earnings releases of
the Issuer for the quarter ending June 30, 2001. Effective August 9, 2001, the
conversion price of the Series F Preferred was reset to $0.9060 and, pursuant to
the terms of the Purchase Agreement, each share of Series F Preferred is
convertible into 122.4503 shares of common stock.
Page 4 of 5
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: August 16, 2001.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
By /s/ DOUGLAS E. SCOTT
------------------------------------------
Douglas E. Scott
Senior Vice President and General Counsel
SAIC VENTURE CAPITAL CORPORATION
By /s/ WILLIAM A. ROPER, JR.
------------------------------------------
William A. Roper, Jr.
Chairman of the Board
Page 5 of 5